Hanlin Zeng

894 total citations
14 papers, 511 citations indexed

About

Hanlin Zeng is a scholar working on Molecular Biology, Oncology and Cell Biology. According to data from OpenAlex, Hanlin Zeng has authored 14 papers receiving a total of 511 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 7 papers in Oncology and 4 papers in Cell Biology. Recurrent topics in Hanlin Zeng's work include Cutaneous Melanoma Detection and Management (4 papers), Histone Deacetylase Inhibitors Research (3 papers) and melanin and skin pigmentation (3 papers). Hanlin Zeng is often cited by papers focused on Cutaneous Melanoma Detection and Management (4 papers), Histone Deacetylase Inhibitors Research (3 papers) and melanin and skin pigmentation (3 papers). Hanlin Zeng collaborates with scholars based in China, United States and Canada. Hanlin Zeng's co-authors include Mary Pat Moyer, Katie M. Reindl, Meiyu Geng, Robert L. Judson‐Torres, Min Huang, Jun Xu, Yi Chen, Jian Ding, Chenchu Lin and Nan Jin and has published in prestigious journals such as Nature, Cancer Cell and Scientific Reports.

In The Last Decade

Hanlin Zeng

12 papers receiving 511 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hanlin Zeng China 8 347 190 93 66 52 14 511
Brian C. Grieb United States 10 401 1.2× 148 0.8× 74 0.8× 34 0.5× 48 0.9× 16 561
Daeun You South Korea 12 213 0.6× 159 0.8× 85 0.9× 44 0.7× 47 0.9× 22 438
Rachana Trivedi India 8 388 1.1× 146 0.8× 98 1.1× 87 1.3× 29 0.6× 11 560
Masato Komatsu Japan 11 322 0.9× 103 0.5× 79 0.8× 42 0.6× 47 0.9× 14 441
Junyu He China 13 230 0.7× 118 0.6× 80 0.9× 92 1.4× 66 1.3× 29 433
Licai He China 12 357 1.0× 127 0.7× 118 1.3× 99 1.5× 26 0.5× 21 538
Shuping Xu United States 13 304 0.9× 105 0.6× 96 1.0× 49 0.7× 24 0.5× 18 467
Juan Yan China 11 386 1.1× 78 0.4× 121 1.3× 79 1.2× 23 0.4× 24 565
Farah Ballout United States 13 229 0.7× 181 1.0× 84 0.9× 28 0.4× 30 0.6× 30 530
Jianping Chen China 11 253 0.7× 205 1.1× 82 0.9× 68 1.0× 17 0.3× 20 451

Countries citing papers authored by Hanlin Zeng

Since Specialization
Citations

This map shows the geographic impact of Hanlin Zeng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hanlin Zeng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hanlin Zeng more than expected).

Fields of papers citing papers by Hanlin Zeng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hanlin Zeng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hanlin Zeng. The network helps show where Hanlin Zeng may publish in the future.

Co-authorship network of co-authors of Hanlin Zeng

This figure shows the co-authorship network connecting the top 25 collaborators of Hanlin Zeng. A scholar is included among the top collaborators of Hanlin Zeng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hanlin Zeng. Hanlin Zeng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Zhang, Li, et al.. (2024). SPRR1B+ keratinocytes prime oral mucosa for rapid wound healing via STAT3 activation. Communications Biology. 7(1). 1155–1155. 3 indexed citations
2.
Chen, Yinan, et al.. (2024). FADD amplification is associated with CD8 + T‐cell exclusion and malignant progression in HNSCC. Oral Diseases. 30(8). 5007–5021. 1 indexed citations
3.
Smith, Eric A., R.L. Belote, Nelly M. Cruz, et al.. (2024). Receptor tyrosine kinase inhibition leads to regression of acral melanoma by targeting the tumor microenvironment. Journal of Experimental & Clinical Cancer Research. 43(1). 317–317. 1 indexed citations
5.
Wang, Xiaomin, Jun Xu, Yiming Sun, et al.. (2023). Hedgehog pathway orchestrates the interplay of histone modifications and tailors combination epigenetic therapies in breast cancer. Acta Pharmaceutica Sinica B. 13(6). 2601–2612. 16 indexed citations
6.
Tao, Ye, Ronghui Xia, Ming Lei, et al.. (2022). Clinical utilization of olaparib, a PARP inhibitor, in BRCA1-mutant metastatic acral melanoma. Genes & Diseases. 10(5). 1755–1758. 6 indexed citations
7.
Ma, Yanni, Ronghui Xia, Xuhui Ma, Robert L. Judson‐Torres, & Hanlin Zeng. (2021). Mucosal Melanoma: Pathological Evolution, Pathway Dependency and Targeted Therapy. Frontiers in Oncology. 11. 702287–702287. 37 indexed citations
8.
Tang, Jessica, Eleanor Fewings, Darwin Chang, et al.. (2021). Publisher Correction: The genomic landscapes of individual melanocytes from human skin. Nature. 590(7844). E20–E20.
9.
Tang, Jessica, Eleanor Fewings, Darwin Chang, et al.. (2020). The genomic landscapes of individual melanocytes from human skin. Nature. 586(7830). 600–605. 83 indexed citations
10.
Zeng, Hanlin, Aparna Jorapur, A. Hunter Shain, et al.. (2018). Bi-allelic Loss of CDKN2A Initiates Melanoma Invasion via BRN2 Activation. Cancer Cell. 34(1). 56–68.e9. 86 indexed citations
11.
Zeng, Hanlin, Jia Qu, Nan Jin, et al.. (2016). Feedback Activation of Leukemia Inhibitory Factor Receptor Limits Response to Histone Deacetylase Inhibitors in Breast Cancer. Cancer Cell. 30(3). 459–473. 134 indexed citations
12.
Lu, Junyan, Hanlin Zeng, Zhongjie Liang, et al.. (2015). Network modelling reveals the mechanism underlying colitis-associated colon cancer and identifies novel combinatorial anti-cancer targets. Scientific Reports. 5(1). 14739–14739. 38 indexed citations
13.
Lin, Chenchu, Hanlin Zeng, Junyan Lu, et al.. (2015). Acetylation at lysine 71 inactivates superoxide dismutase 1 and sensitizes cancer cells to genotoxic agents. Oncotarget. 6(24). 20578–20591. 25 indexed citations
14.
Zeng, Hanlin, et al.. (2013). Activation of ERK signaling and induction of colon cancer cell death by piperlongumine. Toxicology in Vitro. 27(6). 1626–1633. 81 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026